 |
Other News To Note
• Hemispherx Biopharma Inc., of Philadelphia, gained regulatory approval in Argentina for genital wart drug Alferon N Injection, which will be marketed under the trade name Naturaferon. The product will be sold by Hemispherx's Latin American partner GP Pharm SA. Alferon N Injection, a natural interferon, is already FDA approved.